• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淫羊藿素及其衍生物的微生物转化。

Microbial transformation of icariin and its derivatives.

机构信息

College of Pharmacy and Research Institute of Pharmaceutical Sciences, Chonnam National University, Gwangju, Republic of Korea.

出版信息

Nat Prod Res. 2022 Aug;36(16):4103-4113. doi: 10.1080/14786419.2021.1975702. Epub 2021 Sep 10.

DOI:10.1080/14786419.2021.1975702
PMID:34507516
Abstract

Microbial transformation is an important tool to perform selective conversion of compounds to derivatives which are difficult to produce synthetically. In order to obtain icariside II and icaritin, the active components in Herba Epimedii , biotransformation studies using microbes as biocatalysts were carried out. Icariside II () and icaritin () were produced through biotransformation of icariin () using the fungi and var. in 98% and 92% yields, respectively. In the subsequent transformation studies, was deglycosylated to form by , whereas was further converted to a novel compound icaritin-3--β-d-glucopyranoside () and previously known icaritin-3,7--β-d-diglucopyranoside () by . Biological evaluation of these compounds using MTT assay exhibited potent cytotoxic activities against human cancer cell lines A549, A375P, and MCF-7, with icariin being the most active, indicating that glycosylation plays a role in the cytotoxic activity.

摘要

微生物转化是一种重要的工具,可以将化合物选择性地转化为难以通过合成方法得到的衍生物。为了获得淫羊藿中的活性成分朝藿定 II 和朝藿定甲素,我们使用微生物作为生物催化剂进行了生物转化研究。通过真菌 和 var. 对朝藿定苷()进行生物转化,分别以 98%和 92%的产率得到了朝藿定 II()和朝藿定甲素()。在随后的转化研究中,通过 使 去糖基化生成 ,而 进一步转化为一种新的化合物朝藿定甲素-3--β-D-吡喃葡萄糖苷()和之前已知的朝藿定甲素-3,7--β-D-二吡喃葡萄糖苷()。采用 MTT 法对这些化合物进行的生物评价显示,它们对人肺癌细胞系 A549、A375P 和 MCF-7 具有很强的细胞毒性活性,其中朝藿定苷的活性最强,表明糖基化在细胞毒性活性中发挥了作用。

相似文献

1
Microbial transformation of icariin and its derivatives.淫羊藿素及其衍生物的微生物转化。
Nat Prod Res. 2022 Aug;36(16):4103-4113. doi: 10.1080/14786419.2021.1975702. Epub 2021 Sep 10.
2
Icariin Metabolism by Human Intestinal Microflora.人肠道微生物群对淫羊藿苷的代谢
Molecules. 2016 Aug 31;21(9):1158. doi: 10.3390/molecules21091158.
3
Synergistic inhibitory effect of Icariside II with Icaritin from Herba Epimedii on pre-osteoclastic RAW264.7 cell growth.淫羊藿中朝藿定II与淫羊藿素对破骨细胞前体RAW264.7细胞生长的协同抑制作用。
Phytomedicine. 2014 Oct 15;21(12):1633-7. doi: 10.1016/j.phymed.2014.07.016. Epub 2014 Sep 3.
4
Determination of rat urinary metabolites of icariin in vivo and estrogenic activities of its metabolites on MCF-7 cells.淫羊藿苷大鼠体内尿液代谢产物的测定及其代谢产物对MCF-7细胞的雌激素活性研究。
Pharmazie. 2005 Feb;60(2):120-5.
5
Effects of Microbial Transformation on the Biological Activities of Prenylated Chalcones from .微生物转化对来自……的异戊烯基查耳酮生物活性的影响
Foods. 2022 Feb 14;11(4):543. doi: 10.3390/foods11040543.
6
Icaritin Preparation from Icariin by a Special Flavonoid-Glycosidase from sp.y848 Strain.淫羊藿素通过 sp.y848 菌株中的特殊黄酮糖苷酶从淫羊藿苷制备。
J Microbiol Biotechnol. 2022 Apr 28;32(4):437-446. doi: 10.4014/jmb.2112.12036.
7
Preparation of icariside II from icariin by enzymatic hydrolysis method.酶解法制取淫羊藿苷 II。
Fitoterapia. 2010 Jul;81(5):437-42. doi: 10.1016/j.fitote.2009.12.006. Epub 2009 Dec 22.
8
Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro.淫羊藿苷及其糖苷在体外可增强成骨细胞分化和活性,但抑制破骨细胞分化和活性。
Life Sci. 2007 Aug 16;81(10):832-40. doi: 10.1016/j.lfs.2007.07.015. Epub 2007 Jul 27.
9
Potential of Icariin Metabolites from Epimedium koreanum Nakai as Antidiabetic Therapeutic Agents.朝鲜淫羊藿中淫羊藿苷代谢产物作为抗糖尿病治疗药物的潜力。
Molecules. 2017 Jun 13;22(6):986. doi: 10.3390/molecules22060986.
10
Impact of Icariin and its derivatives on inflammatory diseases and relevant signaling pathways.淫羊藿素及其衍生物对炎症性疾病及相关信号通路的影响。
Int Immunopharmacol. 2022 Jul;108:108861. doi: 10.1016/j.intimp.2022.108861. Epub 2022 May 18.

引用本文的文献

1
Small-molecule-based targeted therapy in liver cancer.基于小分子的肝癌靶向治疗。
Mol Ther. 2024 Oct 2;32(10):3260-3287. doi: 10.1016/j.ymthe.2024.08.001. Epub 2024 Aug 8.